KRISTEN HEARD

Podiatric Medicine & Surgery Service Providers|Podiatrist|Foot & Ankle Surgery ERIE, PA NPI 1124468152

General Payments — all program years on this page

$3,552.09

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 124
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $484.65 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $484.6522

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $234.404
2019 $271.7310
2020 $280.4911
2021 $529.7020
2022 $956.8633
2023 $794.2624
2024 $484.6522

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1097076373 Novo Nordisk Inc $17.90 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097117044 Novo Nordisk Inc $22.50 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103897416 ABBVIE INC. $19.47 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103897418 ABBVIE INC. $23.78 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103897420 ABBVIE INC. $15.60 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113903231 Paratek Pharmaceuticals, Inc. $17.18 10/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116638532 GlaxoSmithKline, LLC. $23.40 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117182617 Medtronic, Inc. $16.05 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117882956 Boehringer Ingelheim Pharmaceuticals, Inc. $14.83 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120103898 Kerecis Limited $29.20 12/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124858455 Abbott Laboratories $13.60 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133429303 Averitas Pharma Inc. $22.78 02/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133429307 Averitas Pharma Inc. $19.10 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137441772 Bioventus LLC $21.41 05/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145430919 Organogenesis Inc. $15.48 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145430921 Organogenesis Inc. $19.56 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145430923 Organogenesis Inc. $25.71 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149542163 Smith+Nephew, Inc. $4.25 04/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149542165 Smith+Nephew, Inc. $6.74 08/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149542167 Smith+Nephew, Inc. $18.73 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149542169 Smith+Nephew, Inc. $30.12 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149542171 Smith+Nephew, Inc. $87.26 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.